person

Ari C.

Country
France
Department
Département de pneumologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
95
Sites with multiple studies

Has run more than one trial at 95 of 361 partner sites.

Specializations

Pulmonary Arterial Hypertension

This investigator specializes in the treatment of pulmonary arterial hypertension (PAH), with particular focus on evaluating novel therapeutic approaches for patients across different disease severity levels.

  • Long-term treatment efficacy and safety
  • Advanced PAH management in high-risk patients
  • Combination therapy approaches

The research encompasses both newly diagnosed cases and patients with progressive disease states.

Chronic Pulmonary Conditions

The investigator conducts research in chronic obstructive pulmonary disease (COPD) and its associated complications, including pulmonary hypertension secondary to COPD.

  • PH-COPD treatment strategies
  • Cardiopulmonary outcomes
  • Inhaled therapeutic combinations

Special attention is given to innovative inhalation therapies and their effects on exercise capacity.

Thromboembolic Conditions

Research interests extend to chronic thromboembolic pulmonary hypertension (CTEPH), particularly focusing on inoperable cases requiring medical management.

  • Dual oral treatment approaches
  • Treatment-naïve patient care
  • Pulmonary vascular resistance management

The work includes evaluation of various therapeutic combinations for optimal patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.